Drug Type Small molecule drug |
Synonyms Diacerein/aceclofenac/glucosamine, Glucosamine/aceclofenac/diacerein |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), IL-1β inhibitors(Interleukin-1 beta inhibitors), NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H12O8 |
InChIKeyTYNLGDBUJLVSMA-UHFFFAOYSA-N |
CAS Registry13739-02-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis | Phase 3 | India | - |